Reduced APOA4 levels have been observed in the small intestine [353,354] and plasma [355] of patients with IBD, whereas acute administration of APOA4 alleviates inflammatory symptoms in animals with experimental colitis [77]. The gene discussed is APOA4; the disease is inflammatory bowel disease.